glp 1 stop taking Many adults GLP-1 therapy within a year with low restart rates, analysis finds GLP-1 Medication Discontinuation and Weight

Hypomagnesemia (low magnesium) may occur with prolonged diarrhea or inadequate intake

The burden is particularly striking among high-risk populations: up to 70% of patients with type 2 diabetes mellitus (T2DM) are affected by NAFLD, and one in five adults with obesity and diabetes has NASH with clinically relevant fibrosis

This enhanced effectiveness is related to the medicines'capacity to influence both peripheral and central pathways that govern energy balance

In the DARE 19 study patients hospitalized with COVID-19 and with at least one cardiometabolic risk factor (i.e., hypertension, T2DM, atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease) were randomized to dapagliflozin 10 mg daily or placebo for 30 days (232)

But the specifics of dosing, titration speed, and available dose strengths differ in ways that impact the practical experience of using each medication

adolescents aged 1217 with obesity Pros and Cons of Saxenda Pros: Specifically designed and approved for weight loss May be suitable for patients who dont tolerate semaglutide Approved for adolescent use Cons: Requires daily injections , which can be inconvenient for some Weight loss results are generally more modest compared to Wegovy Shorter half-life than semaglutide-based medications Saxenda may be a better fit for patients who are not candidates for semaglutide or who prefer a shorter-acting medication